title: Diffuse skin reaction after changing the etanercept formulation.
authors.forename: R
authors.initials: R
authors.lastname: Caporali
authors.forename: F
authors.initials: F
authors.lastname: Bobbio-Pallavicini
authors.forename: M
authors.initials: M
authors.lastname: Caprioli
authors.forename: E
authors.initials: E
authors.lastname: Scorletti
authors.forename: C
authors.initials: C
authors.lastname: Montecucco
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D002626:Chemistry, Pharmaceutical; D003875:Drug Eruptions / Q000209:etiology*; D000068800:Etanercept; D005260:Female; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects*; D008875:Middle Aged; D018124:Receptors, Tumor Necrosis Factor
chemical_list: D018501:Antirheumatic Agents; D007074:Immunoglobulin G; D018124:Receptors, Tumor Necrosis Factor; D000068800:Etanercept